I am a
Home I AM A Search Login

Papers of the Week


2019 Apr


Headache


59


4

Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine.

Authors

Rosen N, Pearlman E, Ruff D, Day K, Jim Nagy A
Headache. 2019 Apr; 59(4):627-628.
PMID: 30973202.